{
  "ticker": "RAC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971697",
  "id": "02971697",
  "pages": 9,
  "price_sensitive": true,
  "date": "20250723",
  "time": "0828",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lkvkgrhfpk.pdf",
  "summary": "### **Race Oncology Ltd \u2013 ASX Announcement Summary (Quarterly Report \u2013 Appendix 4C)**  \n\n#### **Material Information for Trading/Capital Markets Decisions**  \n- **Clinical Milestones**:  \n  - First patient dosed with **RC220 alone** and **RC220 + doxorubicin** in Phase 1 trial for advanced solid tumours (no adverse events reported).  \n  - Post-quarter: Ethics approval received for Phase 1 trial at **Prince of Wales and Queen Mary Hospitals (Hong Kong)**.  \n\n- **Leadership Changes**:  \n  - Appointment of **Dr. Jose Iglesias (CMO)** and **Dr. Simon Fisher (VP of Medical)**.  \n\n- **Cash Position**:  \n  - **Closing cash balance: $13.67m** (sufficient to fund operations through CY2026).  \n  - Quarterly R&D spend: **$3.11m** (83% of total expenses).  \n\n- **IP Update**:  \n  - Termination of **City of Hope license agreement** (deemed no longer valuable; retains full freedom to operate with bisantrene).  \n\n- **Shareholder Structure**:  \n  - **Top 20 holders control 33.54%**. Largest holder: **CEO Dr. Daniel Tillett (10.13%)**.  \n\n#### **Excluded (Non-Material)**  \n- Routine investor presentations (Gold Coast Showcase, ESMO 2025 selection).  \n- Minor option conversions ($28k raised).  \n- Director fee disclosures.  \n\n**Format:** Consistent with Appendix 4C requirements; extracted only material operational/financial data impacting valuation or liquidity.  \n\n*No capital raising, trading halt, or other material corporate actions identified.*",
  "usage": {
    "prompt_tokens": 5728,
    "completion_tokens": 352,
    "total_tokens": 6080,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-22T22:50:43.241069"
}